Skip to content
Certified ManufacturersFor manufacturers

XYMOGEN INC.

Orlando, FL, United States

Due-diligence report

Find an accredited testing lab and confirm its scope covers your product and methods.

XYMOGEN INC. is a dietary supplement manufacturer in Orlando, FL, United States, certified to NSF/ANSI 455-2 GMP, with 1 manufacturing facility on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. Listed dosage forms: capsules, powders, softgels and tablets.

Facilities listed
1
Last checked

Dosage forms

As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.

Certified facilities

Manufacturing (1)

  • 6900 Kingspointe Parkway, Orlando, FL 32819, United States

    • Coating
    • Dry Formulation
    • Encapsulation
    • Kits
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Dispensing
    • Packaging/Labeling Operation - Primary Packaging
    • Packaging/Labeling Operation - Secondary Packaging
    • Quality Unit Operations
    • Tablet Compression
    • Warehousing

How XYMOGEN INC. compares

Among the 769 manufacturers we list, as of our last check.

FDA recall records

FDA lists 2 recalls matching the name XYMOGEN INC., as of .

  • Class III · Unlikely to cause health problems

    Reported

    Closed by FDA

    Product was labeled as a medical food as opposed to a dietary supplement.

    2 products, first listed: XYMOGEN LipiChol (Omega-3 Phospholipid 540 mg) Medical Food Distributed by Xymogen Orlando, Florida. Also sold and distributed under various brands and firms:…

    See all 2 products
    • XYMOGEN LipiChol (Omega-3 Phospholipid 540 mg) Medical Food Distributed by Xymogen Orlando, Florida. Also sold and distributed under various brands and firms: *1. 4XLipidComplete (Omega-3 Phospholipid 540 mg) Medical Food Distributed by: N2 Health, La Quinta, CA. *2. AL Metabolic P Manufactured for Integrated Medical Center, Mesa AZ. *3. AstaMega-3 Balance Medical Food Distributed by: Lifestyle Research, Cheyenne, WY. *4.Body Balance H.E.M.M.L.A. Manufactured for: Health Masters, Auburndale, FL. *5. Cardio Protect Manufactured for: Shop The Care Group, LLC, Aurora, CO *6. Cardio-Krill Manufactured for: Whole Health Center, Lone Tree, CO. *7. CardiOmega Distributed by: Vail Valley Pharmacy, Edwards, CO. *8. CholeCare Manufactured for: Dr. Christina M. Tondora Scottsdale, AZ. *9. CHOLESTO-BUST Manufactured for: Clear Sky Medical, Centennial, CO. *10. Manufactured for: Arne Chiropractic & Wellness Center PC, Littleton, CO. *11. Dr. Elkin's CardioBlend Manufactured for: Medical Advocated Inc. Whittier, CA. *12. FaB Fats Manufactured for:Bukovina, Auburn, CA. *13. FEM Lipid Support Manufactured for:FEM Centre, Fort Worth, TX. *14.InflmmaChol Distributed By: INNER SCIENCE, Denver, CO. *15. Integrative Bio-Omega Distributed By: Center for Integrative Bio-Energetics, Santa Monica, CA. *16. ItisControl Distributed By: The 2nd Opinion Inc.Chattanooga, OK. *17. Killer Krill Manufactured for: Integrated Medical Care, Littleton, CO. *18. 360 Medicine Krill Pills Manufactured for: Russ Canfield, MD Santa Fe, NM. *19. Krill Supreme Manufactured for: Health Bridge, Great Neck, NY. *20. Krill-Xanthin Manufactured for: Envita Lifestyle, Scottsdale, AZ. *21. " Li-Chol Manufactured for: Pierce Integrative Medical Center, West Bloomfield, MI. *22. Antarctic Omega Cholesterol Free Distributed By: Villa Park Medical , Villa Park, CA. *23.Lipechol Manufactured For: Women's View Medical Group Holistic Center for Integrated Family Health Care, Upland, CA. *24. Lipical Manufactured For: Ruben Ruiz, M.D.,Montebello, CA. *25. Lipicare Manufactured For: Center for Optimum Health, Los Angeles, CA. *26. Lipichol Krill Mfd for: Longevity Orthopedic Center Inc., Mission Viejo, CA. *27. Lipicontrol Distributed By: Dr. Robert Derryberry, D.C., Paso Robles, CA. *28. " Lipid Complete 360 More than a Fish Oil Distributed By: Pure Biotics, LLC, Tustin, CA. *29. Lipid Balance Food Formulated for: Uzzi Reiss, M.D., Beverly Hills, CA. *30. Lipid Complete Distributed By: Advanced Integrative Medicine, Park Meadows Drive, CO. *31. Lipid Support Distributed By: Rehabilitation Chiropractic Care, Mesa, AZ. *32.Lipid ProtX Manufactured For: Inspire, San Diego, CA. *33. LipiKol Manufactured For: Karima Hirani, M.D., MPH, Hirani Wellness Medical Center, Inc. Culver City, CA. *34. LipiKrill Distributed By: Advance Body Dynamics, Centennial, CO. *35. LipidControl Distributed By: Center for Integrative Medicine, Valley Springs, CA. *36. LipidChol Distributed By: Body Hormone Balance, Texarkana, TX. *37. Lipid ProtX Manufactured For: Premier Health and Wellness Screven Edgerton, M.D., Austin, TX. *38. Marine Lipids EPA-DHA Manufactured For: Dr. Cochrans's Nutraceuticals, Tucson, AZ. *39. Omega Antarctica Manufactured For: Mohammed Ali, M.D. Health & Wellness Center, Inc., Lake Forest, CA. *40. Omega Antarctica Manufactured For: Mohammed Ali, M.D. Health & Wellness Center, Inc., San Clemenete, CA. *41. Lipochol Manufactured For: Phillips Clinic, Las Vegas, NV. *42. LipiKrill Manufactured For: Quest for Wellness, Payson, AZ. *43. LipiXanthin-EX Manufactured For: Health Tools LLC, Clarksville, TN. *44. OmegaPhos Distributed By: Therapeutic Lifestyle Center, Idyllwild, CA. *45. Omega Strength Distributed By: Healthy Cells Wellness, Windermere, FL. *46. OmegaPhos Manufactured For: Dr. Chris Fiorentino, Santa Ana, CA. *47. Omega Supreme Krill Manufactured For: NutriMedical Inc., Vista, CA. *48. OmegaXan Krill Oil Distributed By: True Wellness LLC, Austin, TX. *49. Phospholopid
    • LipiChol 540 (Omega-3 Phospholipid) Medical Food Dispense by Prescription Distributed by: PharmaceutiX Orlando, Florida

    Listed by FDA as Atlantic Pro Nutrients, Inc. dba XYMOGEN

    openFDA record
  • Class I · Most serious: could cause serious health problems

    Reported

    Closed by FDA

    Undeclared Soy and Milk on the label.

    Product: XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support Healthy Joint Function, 90 and 180 capsule bottles

    Listed by FDA as Atlantic Pro Nutrients, Inc. dba XYMOGEN

    openFDA record

We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check

FDA inspections

FDA lists 7 food or dietary supplement inspections at facilities matching XYMOGEN INC., from 2011 to 2024, as of . 1 found no objectionable conditions, 4 found conditions the firm was left to correct, and 2 led FDA to recommend official action.

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Orlando, Florida

    Listed by FDA as Xymogen Manufacturing

    8 citations posted:

    • Specifications - components (21 CFR 111.70(b))
    • Specifications - finished dietary supplement (21 CFR 111.70(e))
    • Documentation specifications met; exempted, periodic testing (21 CFR 111.75(d)(1))
    • Master manufacturing record - prepared (21 CFR 111.205(a))
    See all 8 citations
    • Specifications - components (21 CFR 111.70(b))

      For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications, necessary specifications to ensure the specifications for purity, strength, and composition of the dietary supplement are met and limits on contamination to ensure the quality of the dietary supplement.

    • Specifications - finished dietary supplement (21 CFR 111.70(e))

      You did not establish product specifications for identity, purity and composition.

    • Documentation specifications met; exempted, periodic testing (21 CFR 111.75(d)(1))

      You did not document why an exempted product specification is met without verification by periodically testing the finished batch.

    • Master manufacturing record - prepared (21 CFR 111.205(a))

      You did not prepare a written master manufacturing record for each batch size of a dietary supplement that you manufactured.

    • Master manufacturing record - record requirements (21 CFR 111.210)

      Your master manufacturing record did not include all required information.

    • Standard reference materials; criteria for selecting (21 CFR 111.315(d))

      You did not follow laboratory control processes for use of criteria for selecting standard reference materials used in performing tests and examinations.

    • Examination, testing; established criteria (21 CFR 111.315(e))

      You did not establish and follow laboratory control processes for use of test methods and examinations in accordance with established criteria.

    • Examination, testing; scientifically valid (21 CFR 111.320(b))

      You did not identify and use an appropriate scientifically valid method for each established specification for which testing or examination is required to determine whether the specification was met.

    FEI 3004315824

  • No action indicated · No objectionable conditions found

    Inspected

    Orlando, Florida

    Listed by FDA as Xymogen Manufacturing

    FEI 3004315824

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Orlando, Florida

    Listed by FDA as Xymogen Manufacturing

    3 citations posted:

    • Specifications met - quality (21 CFR 111.73)
    • Dietary supplement - protect, contamination (21 CFR 111.415(b))
    • Record - product complaint; findings (21 CFR 111.570(b)(2)(ii)(F))
    Full citation text
    • Specifications met - quality (21 CFR 111.73)

      You did not determine whether you met specifications established to ensure the quality of the dietary supplement.

    • Dietary supplement - protect, contamination (21 CFR 111.415(b))

      You did not protect manufactured dietary supplements from contamination during filling and packaging operations.

    • Record - product complaint; findings (21 CFR 111.570(b)(2)(ii)(F))

      The written record of a product complaint did not include the findings of the investigation and follow-up action taken.

    FEI 3004315824

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Orlando, Florida

    Listed by FDA as Xymogen Manufacturing

    FEI 3004315824

  • Official action indicated · Regulatory or administrative action recommended

    Inspected

    Orlando, Florida

    Listed by FDA as Xymogen Manufacturing

    9 citations posted:

    • Personnel - hygienic practices (21 CFR 111.10(b))
    • Supervisor - qualified (21 CFR 111.13(a))
    • Equipment - design - suitable (21 CFR 111.27(a))
    • Equipment - maintain, clean, sanitize (21 CFR 111.27(d))
    See all 9 citations
    • Personnel - hygienic practices (21 CFR 111.10(b))

      Your personnel did not use hygienic practices to the extent necessary to protect against contamination of components, dietary supplements, or contact surfaces.

    • Supervisor - qualified (21 CFR 111.13(a))

      You have not assigned qualified personnel to supervise the manufacturing of dietary supplements].

    • Equipment - design - suitable (21 CFR 111.27(a))

      You did not use equipment or utensils of appropriate design, construction, and workmanship to enable them to be suitable for its intended use, adequately cleaned, and properly maintained.

    • Equipment - maintain, clean, sanitize (21 CFR 111.27(d))

      You did not maintain, clean, and sanitize equipment and utensils used to manufacture, package, label, or hold components or dietary supplements.

    • Specifications met - verify; finished batch (21 CFR 111.75(c))

      You did not verify that your finished batch of dietary supplement meets product specifications for identity, purity, strength, and composition.

    • Tests, examinations - scientifically valid (21 CFR 111.75(h))

      You did not ensure that the tests or examinations that you used to determine whether the specifications are met are appropriate, scientifically valid methods.

    • Conditions, controls -protect; microorganisms, contamination (21 CFR 111.365(a))

      You did not perform manufacturing operations under conditions and controls that protect against the potential for growth of microorganisms and the potential for contamination.

    • Hold - mix-up, contamination, deterioration (21 CFR 111.455(c))

      You held components, dietary supplements, and packaging under conditions that lead to mix-up, contamination, or deterioration.

    • Record - product complaint; findings (21 CFR 111.570(b)(2)(ii)(F))

      The written record of a product complaint did not include the findings of the investigation and follow-up action taken.

    FEI 3004315824

Show all 7 inspections
  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Orlando, Florida

    Listed by FDA as Xymogen Manufacturing

    8 citations posted:

    • Specifications - components (21 CFR 111.70(b))
    • Specifications - finished dietary supplement (21 CFR 111.70(e))
    • Documentation specifications met; exempted, periodic testing (21 CFR 111.75(d)(1))
    • Master manufacturing record - prepared (21 CFR 111.205(a))
    See all 8 citations
    • Specifications - components (21 CFR 111.70(b))

      For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications, necessary specifications to ensure the specifications for purity, strength, and composition of the dietary supplement are met and limits on contamination to ensure the quality of the dietary supplement.

    • Specifications - finished dietary supplement (21 CFR 111.70(e))

      You did not establish product specifications for identity, purity and composition.

    • Documentation specifications met; exempted, periodic testing (21 CFR 111.75(d)(1))

      You did not document why an exempted product specification is met without verification by periodically testing the finished batch.

    • Master manufacturing record - prepared (21 CFR 111.205(a))

      You did not prepare a written master manufacturing record for each batch size of a dietary supplement that you manufactured.

    • Master manufacturing record - record requirements (21 CFR 111.210)

      Your master manufacturing record did not include all required information.

    • Standard reference materials; criteria for selecting (21 CFR 111.315(d))

      You did not follow laboratory control processes for use of criteria for selecting standard reference materials used in performing tests and examinations.

    • Examination, testing; established criteria (21 CFR 111.315(e))

      You did not establish and follow laboratory control processes for use of test methods and examinations in accordance with established criteria.

    • Examination, testing; scientifically valid (21 CFR 111.320(b))

      You did not identify and use an appropriate scientifically valid method for each established specification for which testing or examination is required to determine whether the specification was met.

    FEI 3004315824

  • No action indicated · No objectionable conditions found

    Inspected

    Orlando, Florida

    Listed by FDA as Xymogen Manufacturing

    FEI 3004315824

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Orlando, Florida

    Listed by FDA as Xymogen Manufacturing

    3 citations posted:

    • Specifications met - quality (21 CFR 111.73)
    • Dietary supplement - protect, contamination (21 CFR 111.415(b))
    • Record - product complaint; findings (21 CFR 111.570(b)(2)(ii)(F))
    Full citation text
    • Specifications met - quality (21 CFR 111.73)

      You did not determine whether you met specifications established to ensure the quality of the dietary supplement.

    • Dietary supplement - protect, contamination (21 CFR 111.415(b))

      You did not protect manufactured dietary supplements from contamination during filling and packaging operations.

    • Record - product complaint; findings (21 CFR 111.570(b)(2)(ii)(F))

      The written record of a product complaint did not include the findings of the investigation and follow-up action taken.

    FEI 3004315824

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Orlando, Florida

    Listed by FDA as Xymogen Manufacturing

    FEI 3004315824

  • Official action indicated · Regulatory or administrative action recommended

    Inspected

    Orlando, Florida

    Listed by FDA as Xymogen Manufacturing

    9 citations posted:

    • Personnel - hygienic practices (21 CFR 111.10(b))
    • Supervisor - qualified (21 CFR 111.13(a))
    • Equipment - design - suitable (21 CFR 111.27(a))
    • Equipment - maintain, clean, sanitize (21 CFR 111.27(d))
    See all 9 citations
    • Personnel - hygienic practices (21 CFR 111.10(b))

      Your personnel did not use hygienic practices to the extent necessary to protect against contamination of components, dietary supplements, or contact surfaces.

    • Supervisor - qualified (21 CFR 111.13(a))

      You have not assigned qualified personnel to supervise the manufacturing of dietary supplements].

    • Equipment - design - suitable (21 CFR 111.27(a))

      You did not use equipment or utensils of appropriate design, construction, and workmanship to enable them to be suitable for its intended use, adequately cleaned, and properly maintained.

    • Equipment - maintain, clean, sanitize (21 CFR 111.27(d))

      You did not maintain, clean, and sanitize equipment and utensils used to manufacture, package, label, or hold components or dietary supplements.

    • Specifications met - verify; finished batch (21 CFR 111.75(c))

      You did not verify that your finished batch of dietary supplement meets product specifications for identity, purity, strength, and composition.

    • Tests, examinations - scientifically valid (21 CFR 111.75(h))

      You did not ensure that the tests or examinations that you used to determine whether the specifications are met are appropriate, scientifically valid methods.

    • Conditions, controls -protect; microorganisms, contamination (21 CFR 111.365(a))

      You did not perform manufacturing operations under conditions and controls that protect against the potential for growth of microorganisms and the potential for contamination.

    • Hold - mix-up, contamination, deterioration (21 CFR 111.455(c))

      You held components, dietary supplements, and packaging under conditions that lead to mix-up, contamination, or deterioration.

    • Record - product complaint; findings (21 CFR 111.570(b)(2)(ii)(F))

      The written record of a product complaint did not include the findings of the investigation and follow-up action taken.

    FEI 3004315824

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Orlando, Florida

    Listed by FDA as Xymogen Manufacturing

    2 citations posted:

    • Written procedures - product complaint (21 CFR 111.553)
    • Record - product complaint; findings (21 CFR 111.570(b)(2)(ii)(F))
    Full citation text
    • Written procedures - product complaint (21 CFR 111.553)

      You did not establish written procedures for the requirements to review and investigate a product complaint.

    • Record - product complaint; findings (21 CFR 111.570(b)(2)(ii)(F))

      The written record of a product complaint did not include the findings of the investigation.

    FEI 3004315824

  • Official action indicated · Regulatory or administrative action recommended

    Inspected

    Orlando, Florida

    Listed by FDA as Xymogen Manufacturing

    8 citations posted:

    • Personnel - quality control operations; identified (21 CFR 111.12(b))
    • Personnel - records - training (21 CFR 111.14(b)(2))
    • Quality control operations - packaging, labeling (21 CFR 111.127)
    • Quality control operations - returned dietary supplement (21 CFR 111.130)
    See all 8 citations
    • Personnel - quality control operations; identified (21 CFR 111.12(b))

      You have not identified personnel to be responsible for your quality control operations.

    • Personnel - records - training (21 CFR 111.14(b)(2))

      You did not make and keep documentation of training.

    • Quality control operations - packaging, labeling (21 CFR 111.127)

      You do not have quality control operations for labeling.

    • Quality control operations - returned dietary supplement (21 CFR 111.130)

      You do not have quality control operations for returned dietary supplements.

    • Quality control operations - product complaints (21 CFR 111.135)

      You do not have quality control operations for product complaints.

    • Labels - issuance, use (21 CFR 111.410(b))

      You did not control the issuance and use of labels,

    • Hold - mix-up, contamination, deterioration (21 CFR 111.455(c))

      You held labels under conditions that lead to mix-up, contamination, or deterioration.

    • Written procedures - holding; distributing (21 CFR 111.475(b)(1))

      You did not make and keep written procedures for holding and distributing operations.

    FEI 3004315824

We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check

What XYMOGEN INC. says it offers

From XYMOGEN INC.’s own website, checked . Not verified by us.

Services

  • Private labelShow quote“XYMOGEN’S Private Label Design Service is a powerful tool that can strengthen your brand identity.”
    “XYMOGEN’S Private Label Design Service is a powerful tool that can strengthen your brand identity.”

    Source page · seen on

  • Custom formulationShow quote“We work with you to formulate, source, produce, test, package, label, and ship the nutritional solutions you want for your customers.”
    “We work with you to formulate, source, produce, test, package, label, and ship the nutritional solutions you want for your customers.”

    Source page · seen on

  • Contract manufacturingShow quote“With more than 20 years of experience in manufacturing capsules, tablets, and powders, we are a premier 1-stop contract manufacturing partner.”
    “With more than 20 years of experience in manufacturing capsules, tablets, and powders, we are a premier 1-stop contract manufacturing partner.”

    Source page · seen on

Product certifications it claims

  • KosherShow quote“Kosher-certified formulas are identified as such on the label and product webpage.”
    “Kosher-certified formulas are identified as such on the label and product webpage.”

    Source page · seen on

Commercial details

  • Minimum order: 1 case (24 units per case) (company website)Show quote“There is also a minimum case quantity of 1 case (24 units per case).”
    “There is also a minimum case quantity of 1 case (24 units per case).”

    Source page · seen on

We read the company’s public web pages and keep a claim only when its quote appears on the page. A claim is hidden once we haven’t seen it for 120 days. Spotted something wrong? Tell us · How we collect website claims

What we checked, and what we didn’t

Confirmed from NSF’s public listing

Last checked

  • NSF/ANSI 455-2 GMP certification
  • 1 facility address
  • Dosage forms in the certified scope
  • Operations listed for each facility

Not verified by us

  • Minimum order quantity (MOQ): the smallest order they accept
  • Lead times and current capacity
  • Prices
  • Other certifications, like organic, kosher, halal or NSF Certified for Sport
  • Whether they’re taking new clients
  • Conditions inside the facility. We don’t visit or audit facilities.
  • What the company’s own website says it makes and offers, shown above with quotes

Ask about these in your quote request. How we verify

Other capsule manufacturers in the United States

  1. NSF lists 5 capsule facilities, including one in Tempe, AZ

    Tempe, AZ, United States21stcenturyvitamins.com

    • Capsules
    • Gummies
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    NSF/ANSI 455-2checked Nov 19, 2026
  2. NSF lists a capsule facility in Centennial, CO

    Centennial, CO, United States5280smc.com

    • Capsules
    Operations:
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  3. NSF lists a capsule facility in Garden Grove, CA

    Garden Grove, CA, United Statespackaging.com

    • Capsules
    • Gummies
    • Powders
    • Softgels
    • Tablets
    NSF/ANSI 455-2checked Nov 19, 2026
  4. NSF lists a capsule facility in Ada, MI

    Ada, MI, United Statesamway.com

    • Capsules
    • Powders
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    • +1 more
    NSF/ANSI 455-2checked Nov 19, 2026
  5. NSF lists 2 capsule facilities, including one in Chandler, AZ

    Gilbert, AZ, United Statesadeptlifesciences.com

    • Capsules
    • Liquids
    • Powders
    • Tablets
    Operations:
    • Liquid formulation
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  6. NSF lists a capsule facility in Congers, NY

    Congers, NY, United Statesadhhealth.com

    • Capsules
    • Oils
    • Powders
    • Tablets
    Operations:
    • Coating
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026